Endothelin receptor antagonist (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Endothelin receptor antagonist (investigational), covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) [Phase 2]